Logo
Global Pulse Oximeter Market Outlook, 2026

Global Pulse Oximeter Market Outlook, 2026

Bonafide Research 24-06-2021 173 Pages Figures : 25 Tables : 103
Region : Global Category : Lifescience Medical Devices

1. Koninklijke Philips

2. Beckton Dickinson

3. CASMED (Edwards Lifesciences Corporation)

4. Drager Medical Systems Inc.

5. GE Healthcare

More...

A Pulse Oximeter is a small, lightweight & noninvasive device used to monitor the oxygen level in the body. Usually attached to fingertips, this device assesses the pulse rate & displays the oxygen percentage and the current pulse rate. The research report titled Global Pulse Oximeter Market Outlook, 2026 by Bonafide Research categorizes the market to forecast the revenues and analyze the trends in each of the following segments: based on product type (Fingertip, Handheld & Others), based on end-users (Hospital and Health Care Facilities & Home Care), based on region, countries & major companies. The Pulse Oximeter market has been revamped considering the Covid-19 impact.

The growing prevalence of breathing disorders and diseases like asthma, hyperlipidemia, hypertension, diabetes, ischemic conditions, cardiac arrhythmia, sleep apnea, COPD, etc. have been a major market driver for the Pulse Oximeter industry, allowing it to value to USD 1.65 Billion in 2015. A high-quality Pulse Oximeter is critical for the early diagnosis and treatment of patients with Covid-19. Even though the manufacturing & supply chain of the industry suffered challenges due to the pandemic restrictions, the manufactures ensured an adequate supply to the countries in dire need. The market is expected to witness a growth of over 7% CAGR in the forecasted period.

Majorly divided into two types, the handheld segment dominates the market with over half of the share, yet declining in the coming years. The market is driven by a fact that these products are user-friendly and are easy to use in emergency cases. A rise in the number of stroke cases and surgeries is anticipated to boost market growth over the forecast period. The market shift is a result of technological advancements such as easy transfer of data, extensive memory, alarm system, and Bluetooth feature. Through the forecasted period, the fingertip segment is to grow with a CAGR of over 10%, recording the highest growth.

The hospitals & health care centers hold a clear dominance in the Pulse Oximeter market accounting closely to 90% in the year 2020. It is due to an increase in the number of surgeries and emergency room visits across the world. The Covid-19 pandemic has restricted the visits to medical facilities hindering medical care services, giving a hike in the homecare segment. With the increasing awareness of self-monitoring, people are now actively participating in health management from their homes themselves, augmenting the demand for such monitoring devices. The home care segment is expected to demonstrate growth of 15.42% in the coming years.

North America dominated the market, holding to a share of less than 35% in 2020, owing to increasing awareness of respiratory vitals monitoring among the common population. Recent changes in regulatory norms in Europe, which is the second-largest market, are expected to affect all medical device manufacturers. Although the Asia Pacific has a slightly declining birth rate, the number of infants born every day is considerably large. This results in a large target population for CHD. Latin America, along with the Middle East & Africa could hardly contribute to a market share of 15% by the end of the forecasted period.

According to the WHO, around 64 million patients are currently living with COPD worldwide with approximately 90% of deaths due to COPD occurring in low- and middle-income countries. The global market is led by the US, where around 43 states have made pulse oximetry mandatory for newborn screening. Following this, China & Germany contributes to over 12.86% in the year 2020. Other major countries are becoming a popular market for the product due to applications in the detection of Congenital Heart Defects and other heart and respiratory conditions.

Key industry players are undertaking other major initiatives, such as licensing agreements and strategic partnerships, to strengthen their market presence. The market leaders are introducing new products with additional features to sustain them in the competitive market. The Koninklijke Philips NV & CASMED (Edwards Lifesciences Corporation) together accounted for slightly higher than 10% of the total market share. Other major players are Covidien (Medtroni PLCc), Nihon Kohden Corporation, Smiths Medical International, Welch Allyn INC, Spacelabs Healthcare, Meditech, GE Healthcare, etc.

CONSIDERED IN THE REPORT
• Geography: Global
• Base year: 2020
• Historical year: 2015
• Forecasted year: 2026

REGIONS COVERED:
• North America
• Europe
• Asia
• Latin America
• Middle East & Africa

ASPECTS COVERED IN THE REPORT
• Market Size by Value for the period (2015-2026F)
• Market Share by Product type (Fingertip, Handheld & Others)
• Market Share by End User (Hospital and Health Care Facilities & Home Care)
• Market Share by Region
• Market Share by Country
• Market Share by Company

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services